(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.35%) $0.935
(0.60%) $11.02
(0.18%) $0.801
(0.00%) $92.17
Live Chart Being Loaded With Signals
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer...
Stats | |
---|---|
आज की मात्रा | 1.78M |
औसत मात्रा | 1.24M |
बाजार मूल्य | 127.96M |
EPS | $-53.13 ( 2023-09-29 ) |
Last Dividend | $0.360 ( 2023-03-06 ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.29 |
ATR14 | $0.0360 (5.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-06 | Kelly Steven | Buy | 600 000 | Stock Option (Right to Buy) |
2023-06-06 | Zweifach Sanford S | Buy | 38 700 | Stock Option (Right to Buy) |
2023-06-06 | Morris Richard Steven | Buy | 238 000 | Stock Option (Right to Buy) |
2023-06-06 | Torok Michael | Buy | 38 700 | Stock Option (Right to Buy) |
2023-06-06 | Klichinsky Michael | Buy | 238 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
76.64 |
Last 87 transactions |
Buy: 18 644 112 | Sell: 1 508 721 |
मात्रा सहसंबंध
Sesen Bio Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
BOCH | 0.945 |
SHSP | 0.905 |
DYNT | 0.846 |
SGC | 0.836 |
MMAC | 0.83 |
WWD | 0.829 |
SYKE | 0.826 |
LIVE | 0.825 |
DGLY | 0.823 |
ECOR | 0.817 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
GAINL | -0.898 |
APOP | -0.887 |
TDAC | -0.884 |
RMRM | -0.88 |
ISNS | -0.872 |
SVOK | -0.829 |
VERA | -0.822 |
AHPI | -0.801 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Sesen Bio Inc सहसंबंध - मुद्रा/वस्त्र
Sesen Bio Inc वित्तीय
Annual | 2022 |
राजस्व: | $40.00M |
सकल लाभ: | $40.00M (100.00 %) |
EPS: | $-1.990 |
FY | 2022 |
राजस्व: | $40.00M |
सकल लाभ: | $40.00M (100.00 %) |
EPS: | $-1.990 |
FY | 2021 |
राजस्व: | $26.54M |
सकल लाभ: | $0.00 (0.00 %) |
EPS: | $-0.00184 |
FY | 2020 |
राजस्व: | $11.24M |
सकल लाभ: | $11.24 (0.00 %) |
EPS: | $-0.190 |
Financial Reports:
No articles found.
Sesen Bio Inc Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.360 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.360 | 2023-03-06 |
Last Dividend | $0.360 | 2023-03-06 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.360 | -- |
Avg. Dividend % Per Year | 18.77% | -- |
Score | 4.82 | -- |
Div. Sustainability Score | 5.13 | |
Div.Growth Potential Score | 0.276 | |
Div. Directional Score | 2.70 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.360 | 56.30% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1.605 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.761 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.910 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.53 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.27 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 6.42 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0257 | -1.500 | 9.57 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.34 | 1.000 | 6.91 | 6.91 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0199 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0166 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0593 | -1.500 | 9.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.510 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.292 | 1.000 | 9.49 | 9.49 | [0.2 - 2] |
assetTurnoverTTM | 0.474 | 0.800 | -0.172 | -0.138 | [0.5 - 2] |
Total Score | 5.13 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.312 | 1.000 | -0.133 | 0 | [1 - 100] |
returnOnEquityTTM | -0.910 | 2.50 | -7.21 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0166 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0199 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0158 | 1.000 | -2.10 | 0 | [0.1 - 0.5] |
Total Score | 0.276 |
Sesen Bio Inc
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं